7Baggers
 published on: 2025-11-02 23:04:52  newser.com Mon, 03 Nov 2025 05:05:51 GMT

Regulus Therapeutics Inc
(NASDAQ:RGLS) 

RGLS stock logo

Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that target microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in clinical trial for the trea...

Founded: 2007
Full Time Employees: 24
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends